×

ISM & Pharma's Merger Monday

12:00 PM ET Mon, 2 July 2012

The FMHR traders weigh in on how to play today's weak manufacturing numbers; Goldman's call on an eight-percent drop in the S&P. Also, China's soft economic data. And Mark Schoenebaum, ISI Group analyst, discusses the merger between Bristol-Myers and Amylin Pharma and whether the pharma sector is on the verge of consolidation.